Dry, comfortable and low-profile sensors for portable EEG acquisition

NeuroCONCISE Ltd，是阿尔斯特大学的一家衍生公司。我们的使命是“为康复和免运动诊断、通讯、控制和娱乐提供负担得起的高质量神经技术和相关服务”。我们有一个解决方案，可以彻底改变创伤性脑损伤(TBI)后意识/意识的评估方式，即使在一个人无法说话或移动的情况下，也可以实现基本的沟通渠道。NeuroCONCISE的平台神经技术(可穿戴)产品经过15年的开发并得到获奖研究的支持，包括：在柔性基板上的非显眼、可隐藏的电子产品，用于使用高精度的脑电(EEG)记录大脑信号；将大脑活动转换为准确控制信号的先进算法；临床评估/诊断增强软件；以及基本通信和神经技术培训系统。这项技术围绕着我们与技术互动的能力，通过想象运动和调节大脑活动来控制脑机接口(BCI)，即神经技术。NeuroCONCISE成立于2016年，目前由Innovate UK资助，与英国和爱尔兰的17个脑损伤单位(包括13个NHS/HSC信托基金)建立了合作伙伴关系，以试验这项技术，并在爱尔兰和英国获得了伦理批准，可以对长期意识障碍(PDoC)患者进行试验。目前已有计划开发阿尔斯特大学进行的研究，为更大且不断增长的市场需求提供中风康复技术。NeuroCONCISE的平台神经技术还可以提供视频游戏控制，使用运动图像或视觉诱发电位(VEP)，运动图像涉及肢体运动的想象，以唤起特定频率的神经电位，视觉诱发电位是屏幕上呈现的刺激，在特定时间段闪烁或移动，以唤起时间锁定的神经电位。稳固的游戏市场可以从使用EEG的运动独立游戏控制中受益，也可以用来增强传统游戏控制器，为玩家提供更身临其境和更个人化的游戏体验。该项目将使NeuroCONCISE能够开发干式EEG电极技术，与我们的电子EEG处理硬件一起工作，为临床、研究和消费市场生产最具创新性、不引人注目、灵活、便携、用户友好和高质量的EEG设备。

NeuroCONCISE Ltd, is an Ulster University spinout company. Our mission is "to provide affordable, high quality neurotechnology and related services for rehabilitation and movement-free diagnostics, communication, control and entertainment".We have a solution that can revolutionize the way consciousness/awareness can be assessed following traumatic brain injury (TBI) and basic communication channels can be realized, even when a person is unable to speak or move. Developed over 15 years and underpinned by award-winning research, NeuroCONCISE's platform neurotechnology (wearable) product, comprises; unobtrusive, concealable electronics on a flexible substrate for recording brain signals using electroencephalography (EEG) with high precision; advanced algorithms that translate brain activity into accurate control signals; clinical assessment/diagnostic augmentation software; and a basic communication and neurotechnology training system. The technology centres around our ability to interact with technology by imagining movement and modulating brain activity to control a brain-computer interface (BCI) i.e., neurotechnology. NeuroCONCISE was founded in 2016, is currently Innovate UK funded, has partnerships with 17 brain injury units (including 13 NHS/HSC trusts) across the UK and Ireland to trial the technology and has ethical approval in Ireland and the UK to conduct trials with prolonged disorders of consciousness (PDoC) patients. Plans are in place to develop research undertaken at Ulster University to provide stroke rehabilitation technology for a larger and growing market need.NeuroCONCISE's platform neurotechnology can also offer video game control using either motor imagery which involves the imagination of limb movements to evoke frequency-specific neural potentials or visual evoked potentials (VEPs), which are stimuli presented on-screen that are flashed or moved at specific time periods to evoke time-locked neural potentials. The heavily established gaming market can benefit from movement independent game control using EEG and also be used to augment traditional game controllers to provide the player with a more immersive and personal gaming experience.This project will enable NeuroCONCISE to develop dry EEG electrode technology that works alongside our electronic EEG processing hardware to produce the most innovative, unobtrusive, flexible, portable, user-friendly and quality EEG device for the clinical, research and consumer markets.